These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3726874)

  • 1. Mechanisms of toxicity and tolerance to diisopropylphosphorofluoridate at the neuromuscular junction of the rat.
    Gupta RC; Patterson GT; Dettbarn WD
    Toxicol Appl Pharmacol; 1986 Jul; 84(3):541-50. PubMed ID: 3726874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms involved in the development of tolerance to DFP toxicity.
    Gupta RC; Patterson GT; Dettbarn WD
    Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S17-28. PubMed ID: 4092885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of cycloheximide and diisopropylphosphorofluoridate (DFP) during subchronic administration in rat.
    Gupta RC; Dettbarn WD
    Toxicol Appl Pharmacol; 1987 Aug; 90(1):52-9. PubMed ID: 3629591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diisopropylphosphorofluoridate-induced cholinergic hyperactivity and lipid peroxidation.
    Yang ZP; Dettbarn WD
    Toxicol Appl Pharmacol; 1996 May; 138(1):48-53. PubMed ID: 8658512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of phenytoin, ketamine, and atropine methyl nitrate in preventing neuromuscular toxicity of acetylcholinesterase inhibitors soman and diisopropylphosphorofluoridate.
    Clinton ME; Misulis KE; Dettbarn WD
    J Toxicol Environ Health; 1988; 24(4):439-49. PubMed ID: 3411630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of nitric oxide in myotoxicity produced by diisopropylphosphorofluoridate (DFP)-induced muscle hyperactivity.
    Gupta RC; Milatovic D; Dettbarn WD
    Arch Toxicol; 2002 Dec; 76(12):715-26. PubMed ID: 12451448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of diisopropylphosphorofluoridate-induced myopathy by botulinum toxin type A blockage of quantal release of acetylcholine.
    Sket D; Dettbarn WD; Clinton ME; Misulis KE; Sketelj J; Cucek D; Brzin M
    Acta Neuropathol; 1991; 82(2):134-42. PubMed ID: 1927269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different role of carboxylesterases in toxicity and tolerance to paraoxon and DFP.
    Dettbarn WD; Yang ZP; Milatovic D
    Chem Biol Interact; 1999 May; 119-120():445-54. PubMed ID: 10421482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of uptake of [14C]valine into protein in the development of tolerance to diisopropylphosphorofluoridate (DFP) toxicity.
    Gupta RC; Dettbarn WD
    Toxicol Appl Pharmacol; 1986 Jul; 84(3):551-60. PubMed ID: 3726875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of high-energy phosphate compounds in the skeletal muscles of rats intoxicated with diisopropylphosphorofluoridate (DFP) and Soman.
    Gupta RC; Dettbarn WD
    Fundam Appl Toxicol; 1987 Apr; 8(3):400-7. PubMed ID: 3569710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spin trapping agent phenyl-N-tert-butylnitrone prevents diisopropylphosphorofluoridate-induced excitotoxicity in skeletal muscle of the rat.
    Milatovic D; Zivin M; Hustedt E; Dettbarn WD
    Neurosci Lett; 2000 Jan; 278(1-2):25-8. PubMed ID: 10643792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of muscarinic receptor density and acetylcholinesterase activity in repeated DFP-treated rats after the termination of DFP administration.
    Lim DK; Hoskins B; Ho IK
    Eur J Pharmacol; 1986 Apr; 123(2):223-8. PubMed ID: 3709665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and histochemical alterations following acute soman intoxication in the rat.
    Gupta RC; Patterson GT; Dettbarn WD
    Toxicol Appl Pharmacol; 1987 Mar; 87(3):393-402. PubMed ID: 3564014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in the recovery of brain acetylcholinesterase activity following a single exposure to DFP.
    Smolen A; Smolen TN; Han PC; Collins AC
    Pharmacol Biochem Behav; 1987 Apr; 26(4):813-20. PubMed ID: 3602038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cholinergic and neuromuscular toxicity following acute exposure to sarin and VX in rat.
    Gupta RC; Patterson GT; Dettbarn WD
    Fundam Appl Toxicol; 1991 Apr; 16(3):449-58. PubMed ID: 1855618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of diisopropylphosphorofluoridate (DFP)-induced skeletal muscle fiber lesions in rat.
    Patterson GT; Gupta RC; Misulis KE; Dettbarn WD
    Toxicology; 1988 Mar; 48(3):237-44. PubMed ID: 3344523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diisopropylphosphorofluoridate-induced muscle hyperactivity associated with enhanced lipid peroxidation in vivo.
    Yang ZP; Morrow J; Wu A; Roberts LJ; Dettbarn WD
    Biochem Pharmacol; 1996 Jul; 52(2):357-61. PubMed ID: 8694861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the development of behavioral tolerance to organophosphates. II: Neurophysiological aspects.
    Melchers BP; van Helden HP
    Pharmacol Biochem Behav; 1990 Feb; 35(2):321-5. PubMed ID: 2157228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and chronic studies with the anticholinesterase Huperzine A: effect on central nervous system cholinergic parameters.
    Laganière S; Corey J; Tang XC; Wülfert E; Hanin I
    Neuropharmacology; 1991 Jul; 30(7):763-8. PubMed ID: 1922687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of physostigmine and exercise on choline acetyltransferase and acetylcholinesterase activities in fast and slow muscles of rat.
    Babu SR; Somani SM; Dube SN
    Pharmacol Biochem Behav; 1993 Jul; 45(3):713-7. PubMed ID: 8332628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.